JPRN-UMIN000052534RecruitingUnknown
Pathophysiological assessment by FAPI-PET targeting cancer-associated fibroblasts in proton therapy - Pathophysiological assessment by FAPI-PET in proton therapy
Southern Tohoku Research Institute for Neuroscience0 sites80 target enrollmentStarted: October 18, 2023Last updated:
Conditions
Trial Snapshot
- Phase
- Unknown
- Status
- Recruiting
- Sponsor
- Enrollment
- 80
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- ot applicable to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1) Pregnant women, lactating women, and women who may be pregnant (2) Pediatric patients who require sedation (3) Patients whom the principal investigator or co-investigators deem inappropriate to conduct this study.
Investigators
Similar Trials
Active, not recruiting
Phase 1
PET/CT imaging with FAPI as a biomarker for the distinction between predominant active fibrotic and inflammatory phenotypes in patients with progressive pulmonary fibrosis.Progressive Pulmonary Fibrosis (PPF)MedDRA version: 21.0Level: PTClassification code: 10037383Term: Pulmonary fibrosis Class: 100000004855CTIS2023-503686-26-00St Antonius Hospital20
Recruiting
Not Applicable
Evaluation using FAPI-PET targeting cancer-associated fibroblastsCancerJPRN-UMIN000047509Osaka University100
Not yet recruiting
Not Applicable
The diagnostic value of FAPI PET/CT in staging of newly diagnosed PCa10038597Prostate cancerNL-OMON53628Antoni van Leeuwenhoek Ziekenhuis30
Recruiting
Phase 2
Pilot study of FAPI PET/CT for locoregional (re)staging of lymph nodes in colorectal carcinomaBowel cancer10017991colorectal cancerNL-OMON49926Antoni van Leeuwenhoek Ziekenhuis30
Unknown
Not Applicable
Visualized Monitoring of Fibrosis Formation in Heart Failure With 68GA-FAPI PETPositron Emission TomographyHeart FailureNCT04982458Wuhan Union Hospital, China50